indian pharma industry

1. HISTORY
The Pharmaceutical industry in India is the world's
third-largest in
terms of volume.
According to Department of Pharmaceuticals, Ministry
of Chemicals and Fertilizers, the total turnover of India's
pharmaceuticals industry between 2008 and September
2013 was US$21.04 billion. While the domestic market
was worth US$12.26 billion.

2. CONTD...
According to Brand India Equity Foundation, the Indian
pharmaceutical market is likely to grow at a compound
annual growth rate (CAGR) of 14-17 per cent in between
2012-16.
Exports
of pharmaceuticals products from India
increased from US$6.67 billion in 2011–12 to US$9.7
billion in 2012–13 a combined annual growth rate of

3. CURRENT SCENARIO
Currently,
the pharmaceutical industry is also
undergoing unprecedented changes. The introduction of
product patent regime in 2005 has led to the return of
pharmaceutical multinationals to India.
The Indian pharma industry is now focusing on drugs
developed in-house, contract research, contract
production, and particularly in the conduct of clinical trials

4. CONTD...
 The lifestyle drug segment will fuel the growth of India's
pharmaceutical industry which includes antidiabetics,
antiulcer,
antidepressants,
cardiovascular,
antihypertensive, and drugs needed for Alzheimer's
disease, osteoarthritis, cancer, etc.
 Currently, the Indian industries are facing tough
competition from domestic generic markets and other
low-cost drug producing countries, particularly Israel,
China, Korea, and those from East Europe.
 India has the potential to become the region's hub for
pharmaceutical
and
biotechnological
discovery
research, manufacturing, exporting, and healthcare
services within the next decade.

5. TURNOVER IN
PHARMACEUTICAL INDUSTRY
Employee turnover can be disruptive, expensive and
affect team morale. Employees leave for many reasons
,such asexciting work and challenges
career growth, learning and development
working with great people
fair pay
supportive management/good boss

6. CONTD...
 benefits
 great work environment and culture
 creativity
 flexibility
 location
 job security and stability
 fun on the job
 being part of a team
 responsibility
 inspiring leadership

8. TOP 10 PHARMACEUTICAL
COMPANY
 Ranbaxy Labs
With total net sales of Rs 7686.59 crore, Ranbaxy is the
largest pharmaceutical company in India.
 Cipla
With total net sales of Rs 6,977.50 crore Cipla is the second
largest pharmaceutical company in India.
 Dr Reddys Labs
With total net sales of Rs 6,686.30 crore Dr Reddys Labs is
the third largest pharmaceutical company in India.
 Lupin
Lupin is the fourth largest pharma company in India with the
total net sales of Rs 5,364.37 crore.
 Aurobindo Pharma
Aurobindo Pharma is on 5th position with the total net sales
of Rs 4,284.63 crore.

9. CONTD...
 Sun Pharma
Net Sales revenues stood at Rs 4,015.56 crore makes it the sixth
largest pharmaceutical company in India.
 Cadila Health
Cadila Health is the seventh largest pharma company with the total
sales revenue of Rs 3,152.20 crore.
 Jubilant Life
Eight largest company has the total sale revenue at Rs 2,641.07
crore.
 Wockhardt
Wockhardt has the total net sales of 2,560.16 crore and the ninth
largest pharmaceutical company in India.
 Ipca Laboratories
Revenue of Rs 2,352.59 crore makes Ipca India's 10th largest
pharma firm by sales.

10. CHALLENGES
Even after the increased investment, market leaders
such as Ranbaxy and Dr. Reddy’s Laboratories spent
only 5–10% of their revenues on R&D.
 lagging behind Western pharmaceuticals like Pfizer,
whose research budget last year was greater than the
combined revenues of the entire Indian pharmaceutical
industry.

11. CONTD...
 Today, leading domestic pharma companies are global
in nature. They have completely diversified their
portfolio whereby India does not contribute more than
30 per cent of revenues. They are trying to build a
global franchise.
 Among the main challenges, new product approvals
contributed 4-5 per cent of India’s growth and that has
completely disappeared due to the changing regulatory
requirements.

12. GOVT. SUPPORT
The Indian government has been very supportive. It
established the Department of Biotechnology in 1986
under the Ministry of Science and Technology.
Since then, there have been a number of dispensations
offered by both the central government and various states
to encourage the growth of the industry.

13. CONTD...
 India’s science minister launched a program that
provides tax incentives and grants for biotech start-ups
and firms seeking to expand and establishes the
Biotechnology Parks Society of India to support ten
biotech parks by 2015.
 The government has also taken steps to encourage
foreign investment in its pharma sector. An initiative
passed earlier this year allowed 100% foreign direct
investment without compulsory licensing from the
government.